Involvement of DKK1 Secreted From Adipose-Derived Stem Cells in Alopecia Areata

    November 2023 in “ Cell Proliferation ”
    Nahyun Choi, J.-U. Hwang, Doo Yeong Kim, Jino Kim, Seung Yong Song, Jong‐Hyuk Sung
    Image of study
    TLDR A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.
    The study investigated the role of DKK1, a protein secreted from adipose-derived stem cells (ASCs), in alopecia areata (AA), a condition causing hair loss. High DKK1 expression was found in AA patients, suggesting a correlation between DKK1 and hair loss. DKK1 was found to hinder hair follicle enlargement and restrict the proliferation of hair follicle stem cells. However, inhibiting DKK1 stimulated hair growth. The researchers created DKK1 knockout ASCs (DKK1-KO-ASCs) which showed increased hair growth-promoting effects and reduced inflammatory responses, making them a promising cell therapy for treating AA. The DKK1 knockout led to the activation of the WNT pathway, promoting hair growth, and the inactivation of the NF-kB pathway, reducing inflammation.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results

    Related Community Posts Join

    6 / 14 results

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  92 upvotes 2 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.
      [object Object]

      community Has anyone used Magnesium L-Threonate ?

       74 upvotes 6 years ago
      Magnesium L-Threonate may help treat balding by reducing DKK-1 expression without affecting DHT. Users discuss its potential effectiveness and application methods, with some considering trying it topically.

      community Breezula phase 3 results said to be released next month

      in Product  25 upvotes 3 weeks ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.

    Similar Research

    5 / 547 results